The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...

Patients who have plateaued on GLP-1 agents may be able to increase dosing intervals while maintaining metabolic improvements, a case series suggested. (Obesity) Exactly 7 hours a ...

(Viktoriya Skorikova/Moment/Getty Images) GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

In one of the largest analyses ever conducted, researchers found that most side effects blamed on statins aren’t actually caused by the drugs. For the vast majority of patients, the protection against ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

The majority of reported side-effects commonly associated with statins are not directly caused by the drugs themselves, a new study has suggested. Following a comprehensive review of adverse reactions ...

The long list of side effects associated with statins is vastly overstated, according to the most rigorous assessment of the evidence to date. This is prompting calls for the drugs’ packaging to be ...